ARCHIVES

Also Kevin Cullen named director, Univ. of Maryland Greenebaum Cancer Center.

This article is from The Cancer Letter archive.

Vol. 29 No. 44 | November 28, 2003

Download PDF Visit The Full Archive

Related Articles

In Congress: Time Running out On Effort To Double Market Exclusivity Term

November 7, 1997

White House Announces FDA Initiatives To accelerate Cancer Drug Approval

April 4, 1996

NCAB Cancer Centers committee recommends Ratio Cap To Limit Growth of Largest Grants

February 14, 1992

Duke Scores Highest On NCAB Review

July 14, 1978

Avon Gives $3 Million To Expand CDC’s Screening Program

February 18, 1994

Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction”

September 11, 1998